全球生物製藥層析法系統市場

到 2030 年，全球生物製藥層析法系統市場規模將達到 53 億美元

全球生物製藥層析法系統市場規模預計在2024年為33億美元，到2030年將達到53億美元，2024年至2030年的複合年成長率為8.1%。一次性系統是本報告分析的細分市場之一，預計其複合年成長率為9.1%，到分析期結束時規模將達到40億美元。多用途系統細分市場在分析期間的複合年成長率預計為5.3%。

美國市場規模估計為 9.083 億美元，中國市場預計複合年成長率為 12.7%

預計2024年美國生物製藥層析法系統市場規模將達9.083億美元。作為世界第二大經濟體的中國，預計2030年市場規模將達到12億美元，在2024-2030年的分析期間內，複合年成長率為12.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.0%和7.8%。在歐洲，預計德國市場的複合年成長率為5.4%。

全球生物製藥層析法系統市場—主要趨勢和促進因素摘要

為什麼層析法系統在生物製藥製造過程中很重要？

生物製藥生產對複雜性和精度的要求日益提高，這使得層析法系統成為確保產品純度、功效和法規遵循的重要工具。在生物製藥（包括單株抗體、疫苗、荷爾蒙和細胞療法）的開發和生產過程中，層析法在生物分子的分離、純化和分析中起著至關重要的作用。與傳統藥物不同，生物製藥來自生物體，這使得其成分更加多樣化，純化難度更高。層析法系統能夠選擇性地從細胞碎片、宿主細胞蛋白質和雜質中分離蛋白質、核酸和其他生物材料，分離程度通常非常低。這確保了最終產品的安全性和一致性，這對於患者的治療效果以及滿足 FDA、EMA 和 WHO 等監管機構制定的嚴格標準至關重要。此外，將層析法從實驗室擴展到商業生產的能力使生物製藥公司能夠縮短藥物開發時間，同時在各個生產階段保持品管。層析法介質的創新，例如高容量樹脂和整體柱，正在進一步提高系統性能、通量和重現性。隨著個人化醫療和生物製藥需求的不斷成長，生物製藥行業的規模和複雜性不斷成長，層析法系統仍然是可靠、高純度生產工作流程的基石。

技術創新如何提高生物製藥層析法系統的效能？

技術進步正在改變生物製藥層析法系統，使其更快、更準確、自動化程度更高，以滿足現代生物製藥製造不斷變化的需求。最重要的創新領域之一是一次性層析法系統的開發，該系統可降低交叉污染的風險，最大限度地減少清洗驗證要求，並提高操作靈活性。這些系統在需要快速切換的大量生產設施中尤其有用。自動化和數位化整合也透過實現即時監控、高級數據分析和遠端製程控制，徹底改變了層析法操作。軟體主導平台使製造商能夠高精度地微調參數，從而獲得更一致的純化結果並減少批次拒收。此外，與傳統的批量方法相比，連續層析法因其在提高通量、降低樹脂成本和提高製程效率方面的潛力而越來越受歡迎。樹脂化學領域的創新正在推動具有更高選擇性和結合能力的配體的開發，這對於純化複雜或低產量的生物分子至關重要。此外，色譜柱設計和流量分配技術的改進也提高了可擴展性並縮短了處理時間。將離子交換、親和性和和疏水交互作用層析法整合到整合工作流程中的混合系統也越來越受歡迎，為處理各種生物分子提供了更大的靈活性和穩定性。這些創新不僅推動了性能的提升，還幫助生物製藥製造商滿足更嚴格的監管要求，並更快地回應不斷變化的治療需求。

哪些地區和產業趨勢推動了生物製藥領域層析法系統的應用？

區域動態和特定行業需求在生物製藥領域層析法系統的採用和客製化中發揮關鍵作用。北美和歐洲的生物製藥開發成熟且受到嚴格監管，因此對高通量、自動化和合規性的先進層析法平台的投資力度巨大。大型製藥公司、契約製造組織 (CMO) 和成熟的研發基礎設施的存在，支持了層析法在這些市場的持續擴張。此外，這些地區對生物相似藥和非專利生技藥品的需求不斷成長，進一步推動了成本效益高且擴充性的純化技術的應用。相較之下，亞太地區，尤其是中國、印度和韓國，正經歷快速成長，這得益於政府對生物製藥生產的支持、不斷增加的外國投資以及不斷成長的國內製藥市場。這些國家正致力於建構端到端的生物生產能力​​，而層析法系統已成為其生物加工策略的核心要素。同時，拉丁美洲和中東地區正成為潛力巨大的新興地區，這些地區的國家醫療改革和對本地生技藥品生產的日益重視，正在推動對生物製造基礎設施的投資。在所有地區，個人化醫療、細胞和基因治療以及疫情防治的日益重視，推動了人們對靈活、模組化的層析法系統的興趣，這些系統可以輕鬆適應各種生物分子。這些多樣化的區域趨勢使得全球層析法系統市場高度動態化且分散化，老牌企業和新參與企業都在尋找成長機會，以適應區域需求和法規。

哪些因素推動了生物製藥層析法系統的全球成長？

生物製藥層析法系統市場的成長受到與治療方法創新、監管演變、技術進步和生物製造可擴展性相關的幾個關鍵因素的驅動。成長要素是對生物製藥擴大被用於治療慢性和危及生命的疾病，例如癌症、自體免疫疾病和罕見遺傳疾病。隨著正在開發的生技藥品數量的不斷成長，對能夠同時滿足品質和產量要求的可靠、高通量純化技術的需求也在不斷成長。另一個關鍵驅動力是生物製藥的複雜性日益增加，這需要更先進的純化技術，這些技術能夠在不損害產品完整性的情況下去除各種與製程相關的雜質。監管機構也提高了品質期望，迫使製造商實施提供更強控制、可追溯性和文件記錄的系統。一次性技術、連續處理和製程分析技術 (PAT) 的進步使製造商能夠提高生產力、降低成本並加快產品上市速度。此外，向分散式和敏捷製造模式的轉變，尤其是在個人化治療和小規模生產領域，正在催生對模組化和靈活層析法裝置的需求。生物製藥行業日益成長的契約製造和外包趨勢正在進一步加速其應用，因為服務供應商正尋求透過先進的純化能力來提升自身競爭力。最後，公共和私人對生技藥品的投資，尤其是為應對流行病等全球健康威脅而進行的投資，正在推動對可擴展且適應性強的層析法解決方案的需求。這些因素共同推動了全球生物製藥層析法系統市場強勁且持續的成長。

部分

系統類型（一次性系統、多次使用系統）、介質類型（液體介質類型、氣體介質類型）、最終用戶（生物製藥最終用戶、生命科學和學術研究最終用戶、CMO 最終用戶）

受訪公司範例

• Agilent Technologies
• Avantor Inc.
• Bio-Rad Laboratories Inc.
• Bionetix Inc.
• Cytiva（Danaher Corporation）
• Ecolab Life Sciences
• Eppendorf SE
• GE Healthcare Life Sciences（now part of Cytiva）
• Hitachi High-Tech Corporation
• Knauer Wissenschaftliche Gerate
• Merck KGaA（MilliporeSigma in US）
• Mitsubishi Chemical Corporation
• PerkinElmer Inc.
• Phenomenex Inc.
• Purolite（an Ecolab Company）
• Repligen Corporation
• Sartorius AG
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Tosoh Bioscience LLC

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Biopharma Chromatography Systems Market to Reach US$5.3 Billion by 2030

The global market for Biopharma Chromatography Systems estimated at US$3.3 Billion in the year 2024, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Single-Use Systems, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Multi-Use Systems segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$908.3 Million While China is Forecast to Grow at 12.7% CAGR

The Biopharma Chromatography Systems market in the U.S. is estimated at US$908.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 12.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Biopharma Chromatography Systems Market - Key Trends & Drivers Summarized

Why Are Chromatography Systems Crucial to the Biopharmaceutical Manufacturing Process?

The increasing complexity and precision required in biopharmaceutical production have elevated chromatography systems as essential tools for ensuring product purity, efficacy, and regulatory compliance. In the development and manufacturing of biologics, including monoclonal antibodies, vaccines, hormones, and cell-based therapies, chromatography plays a critical role in the separation, purification, and analysis of biomolecules. Unlike traditional pharmaceuticals, biopharmaceuticals are produced from living organisms, making their composition more variable and their purification significantly more challenging. Chromatography systems allow for the selective separation of proteins, nucleic acids, and other biological substances from cell debris, host cell proteins, and impurities, often at very fine levels of distinction. This ensures the safety and consistency of the final product, which is crucial for patient outcomes and meeting the strict standards set by regulatory bodies such as the FDA, EMA, and WHO. Moreover, the ability to scale chromatography from lab to commercial manufacturing supports biopharma companies in speeding up drug development timelines while maintaining quality control across different production stages. Innovations in chromatography media, such as high-capacity resins and monolithic columns, are further enhancing system performance, throughput, and reproducibility. As the biopharma industry continues to grow in both size and complexity, driven by increasing demand for personalized medicine and biologic drugs, chromatography systems remain a backbone technology for reliable, high-purity production workflows.

How Are Technological Innovations Advancing the Performance of Biopharma Chromatography Systems?

Advancements in technology are transforming biopharma chromatography systems, making them faster, more precise, and increasingly automated to meet the evolving needs of modern biologic drug production. One of the most significant areas of innovation is the development of single-use chromatography systems, which reduce cross-contamination risk, minimize cleaning validation requirements, and increase operational flexibility. These systems are particularly valuable in multiproduct facilities where rapid changeovers are required. Automation and digital integration are also revolutionizing chromatography operations by enabling real-time monitoring, advanced data analytics, and remote process control. Through software-driven platforms, manufacturers can now fine-tune parameters with high accuracy, leading to more consistent purification results and reduced batch failures. Furthermore, continuous chromatography, as opposed to traditional batch methods, is gaining traction for its ability to improve throughput, lower resin costs, and increase process efficiency. Innovations in resin chemistry are leading to the development of ligands that offer higher selectivity and binding capacity, which is critical for purifying complex or low-yield biomolecules. In addition, improvements in column design and flow distribution technology are allowing for better scalability and reduced processing times. Hybrid systems that combine ion exchange, affinity, and hydrophobic interaction chromatography in integrated workflows are also becoming more prevalent, offering greater flexibility and robustness in handling diverse biomolecules. These innovations are not only driving performance enhancements but also helping biopharma manufacturers meet tighter regulatory requirements and respond more swiftly to changing therapeutic demands.

What Regional and Industry Trends Are Driving Adoption of Chromatography Systems in Biopharma?

Regional dynamics and specific industry needs are playing a pivotal role in the adoption and customization of chromatography systems in the biopharmaceutical sector. In North America and Europe, where biologic drug development is mature and heavily regulated, there is significant investment in advanced chromatography platforms capable of high throughput, automation, and regulatory compliance. The presence of major pharmaceutical companies, contract manufacturing organizations (CMOs), and well-established R&D infrastructure supports the continued expansion of chromatography usage in these markets. Additionally, increasing demand for biosimilars and generic biologics in these regions is further encouraging the deployment of cost-effective and scalable purification technologies. In contrast, the Asia-Pacific region, particularly China, India, and South Korea, is witnessing rapid growth driven by government support for biopharma manufacturing, increasing foreign investments, and a growing domestic pharmaceutical market. These countries are focusing on building end-to-end bioproduction capabilities, with chromatography systems being a central component of their bioprocessing strategies. Meanwhile, Latin America and the Middle East are emerging as promising regions, where national healthcare reforms and an expanding focus on local biologics production are driving investments in biomanufacturing infrastructure. Across all regions, a growing emphasis on personalized medicine, cell and gene therapies, and pandemic preparedness is shifting focus toward flexible and modular chromatography systems that can be easily adapted for different types of biomolecules. These diverse regional trends are creating a highly dynamic and segmented global market for chromatography systems, with both established players and new entrants finding growth opportunities tailored to local needs and regulations.

What Forces Are Accelerating the Global Growth of Biopharma Chromatography Systems?

The growth in the biopharma chromatography systems market is driven by several critical factors linked to therapeutic innovation, regulatory evolution, technological advancement, and biomanufacturing scalability. A primary growth driver is the rising demand for biologic drugs, which are increasingly used to treat chronic and life-threatening conditions such as cancer, autoimmune disorders, and rare genetic diseases. As the number of biologics in development continues to grow, so too does the need for reliable, high-throughput purification technologies that can meet both quality and production volume requirements. Another key factor is the growing complexity of biopharmaceutical products, which demands more sophisticated purification techniques capable of removing a wide range of process-related impurities without compromising product integrity. Regulatory agencies are also tightening quality expectations, pushing manufacturers to adopt systems that offer higher levels of control, traceability, and documentation. Advances in single-use technology, continuous processing, and process analytical technology (PAT) are enabling manufacturers to improve productivity, reduce costs, and increase speed-to-market. Moreover, the shift toward decentralized and agile manufacturing models, particularly for personalized therapies and smaller batch production, is creating demand for modular, flexible chromatography setups. The expansion of contract manufacturing and outsourcing trends within the biopharma industry is further fueling adoption, as service providers seek to differentiate themselves with advanced purification capabilities. Finally, public and private sector investment in biologics, particularly in response to global health threats such as pandemics, is reinforcing the need for scalable and adaptable chromatography solutions. Together, these factors are driving robust and sustained growth in the global biopharma chromatography systems market.

SCOPE OF STUDY:

The report analyzes the Biopharma Chromatography Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

System Type (Single-Use Systems, Multi-Use Systems); Media Type (Liquid Media Type, Gas Media Type); End-Use (Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use, CMO End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Agilent Technologies
• Avantor Inc.
• Bio-Rad Laboratories Inc.
• Bionetix Inc.
• Cytiva (Danaher Corporation)
• Ecolab Life Sciences
• Eppendorf SE
• GE Healthcare Life Sciences (now part of Cytiva)
• Hitachi High-Tech Corporation
• Knauer Wissenschaftliche Gerate
• Merck KGaA (MilliporeSigma in US)
• Mitsubishi Chemical Corporation
• PerkinElmer Inc.
• Phenomenex Inc.
• Purolite (an Ecolab Company)
• Repligen Corporation
• Sartorius AG
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Tosoh Bioscience LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Biopharma Chromatography Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Booming Biologics and Biosimilars Market Throws the Spotlight on High-Precision Chromatography Systems
  • Rising Demand for Monoclonal Antibodies Spurs Growth in Large-Scale Chromatographic Purification Solutions
  • Here's the Story: How Single-Use Technologies Are Transforming Chromatography System Design in Biopharma
  • Expansion of Contract Manufacturing Organizations (CMOs) Expands Addressable Market for Modular Chromatography Systems
  • Increased Investment in Cell and Gene Therapies Drives Demand for Customizable Separation Technologies
  • Growing Adoption of Continuous Bioprocessing Spurs Innovation in Integrated Chromatography Workflows
  • Here's How High-Throughput Screening and Process Intensification Are Reshaping System Requirements
  • Surging Vaccine Development and Manufacturing Accelerates Global Deployment of Chromatography Equipment
  • Automation and Digitalization Trends Throw the Spotlight on Smart and Software-Enabled Chromatography Systems
  • Rising Interest in Green Chemistry and Sustainable Bioprocessing Generates Demand for Eco-Friendly Chromatography Media
  • Evolving Analytical Requirements in Downstream Processing Create Opportunities for Hybrid and Multi-Modal Chromatography Systems
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Biopharma Chromatography Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Biopharma Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Single-Use Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Single-Use Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Single-Use Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Multi-Use Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Multi-Use Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Multi-Use Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Liquid Media Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Liquid Media Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Liquid Media Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Gas Media Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Gas Media Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Gas Media Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Life Sciences & Academic Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Life Sciences & Academic Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Life Sciences & Academic Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for CMO End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for CMO End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for CMO End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: China 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Biopharma Chromatography Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: France 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Germany 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Italy 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: UK 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Spain 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Russia 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Biopharma Chromatography Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Australia 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: India 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: South Korea 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Biopharma Chromatography Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Latin America 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Argentina 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Brazil 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Mexico 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Biopharma Chromatography Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Middle East 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Iran 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Israel 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: UAE 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Africa 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION